Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aju IB Investment Co., Ltd. (027360:KRX), powered by AI.
Aju IB Investment Co., Ltd. is currently trading at ₩11,330. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Aju IB Investment Co., Ltd. on Alpha Lenz.
Aju IB Investment Co., Ltd.'s P/E ratio is 161.2.
“Aju IB Investment Co., Ltd. trades at a P/E of 161.2 (premium valuation) with modest ROE of 3.2%.”
Ask for details →Aju IB Investment Co., Ltd. is an investment company based in South Korea, specializing in the provision of financial services and funding solutions. The firm primarily focuses on engaging in venture capital activities, private equity investments, and asset management services. Aju IB Investment plays a significant role in catalyzing growth for emerging industries by backing early-stage startups and providing the necessary capital for expansion. It is involved in a diverse range of sectors, including technology, biotechnology, and consumer goods, reflecting a strategic investment portfolio aimed at high-growth potential industries. The company extends its market influence through strategic collaborations and partnerships, supporting innovative business models and promoting economic development within the region. As a key player in South Korea's financial landscape, Aju IB Investment Co., Ltd. contributes to creating a more dynamic investment ecosystem. Its activities not only foster entrepreneurship but also provide investors with opportunities to participate in the growth trajectories of promising businesses. By doing so, Aju IB Investment helps shape the future paths of various transformative sectors.
“Aju IB Investment Co., Ltd. trades at a P/E of 161.2 (premium valuation) with modest ROE of 3.2%.”
Ask for details →Aju IB Investment Co., Ltd. (ticker: 027360) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $1.4T.
The current price is ₩11,330 with a P/E ratio of 161.23x and P/B of 5.14x.
ROE is 3.20%. Annual revenue is $26.9B.